Increased membrane turnover in the brain in cutaneous anthrax without central nervous system disorder: A magnetic resonance spectroscopy study

Medical Hypotheses

Volumn 79, Issue 1, 2012, Pages 43-46

  Bayindir, Yasar ^a   Firat, Ahmet K ^b   Kayabas, Uner ^a   Alkan, Alpay ^c   Yetkin, Funda ^a   Karakas, Hakki M ^d   Yologlu, Saim ^e  

^a INONU UNIVERSITY   (Turkey)

^b MEDICAL PARK HOSPITAL   (Turkey)

^c BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^d stanbul Fatih Sultan Mehmet Training and Research Hospital   (Turkey)

^e INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIUM CULTURE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; COMORBIDITY; FEMALE; HUMAN; MALE; NERVE CELL; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SKIN INFECTION; WHITE MATTER;

ADULT; ANTHRAX; BRAIN; CASE-CONTROL STUDIES; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MODELS, THEORETICAL; SKIN DISEASES, BACTERIAL;

BACILLI (CLASS); BACILLUS ANTHRACIS; POSIBACTERIA;

EID: 84861462020     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.03.027     Document Type: Article

References (23)

1. Stanley J.L., Smith H. Purification of factor I and recognition of a third factor of the anthrax toxin. J Gen Microbiol 1961, 26:49-63.
2. Moayeri M., Leppla S.H. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med 2009, 30:439-455.
3. Martin G.J., Friedlander A.M. Bacillus anthracis (Anthrax). Principles and practice of infectious diseases 2010, 2715-2725. Churchill Livingstone Elsevier, Philadelphia. 7th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
4. Turnbull PCB. WHO Anthrax Working Group. Anthrax in humans and animals. 4th Edition. WHO Guidance, World Health Organization, Geneva, 2008.
5. Doganay M., Metan G. Human anthrax in Turkey from 1990 to 2007. Vector Borne Zoonotic Dis 2009, 9:131-140.
6. Domínguez E., Bustos C., García M., Recio S. Anthrax meningoencephalitis: radiologic findings. AJR Am J Roentgenol 1997, 169:317.
7. Kim H.J., Jun W.B., Lee S.H., Rho M.H. CT and MR findings of anthrax meningoencephalitis: report of two cases and review of the literature. AJNR Am J Neuroradiol 2001, 22:1303-1305.
8. Karakas H.M., Bayindir Y., Firat A.K., Yagmur C., Alkan A., Kayabas U. Cerebral diffusional changes in the early phase of anthrax: is cutaneous anthrax only limited to skin?. J Infect 2006, 52:354-358.
9. Turnbull PCB. Guidelines for the surveillance and control of anthrax in humans and animals (publication no. WHO/EMC/ZDI./98.6). Department of Communicable Diseases Surveillance and Response, World Health Organization, Geneva, 1998.
10. Kayabas U., Alkan A., Firat A.K., Karakas H.M., Bayindir Y., Yetkin F. Magnetic resonance spectroscopy features of normal-appearing white matter in patients with acute brucellosis. Eur J Radiol 2008, 65:417-420.
11. Firat A.K., Karakaş H.M., Firat Y., Yakinci C. Quantitative evaluation of brain involvement in ataxia telangiectasia by diffusion weighted MR imaging. Eur J Radiol 2005, 56:192-196.
12. Mascalchi M., Filippi M., Floris R., Fonda C., Gasparotti R., Villari N. Diffusion-weighted MR of the brain: methodology and clinical application. Radiol Med 2005, 109:155-197.
13. Jernigan J.A., Stephens D.S., Ashford D.A., et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001, 7:933-944.
14. Meyer M.A. Neurologic complications of anthrax: a review of the literature. Arch Neurol 2003, 60:483-488.
15. Vick J.A., Lincoln R.E., Klein F., Mahlandt B.G., Walker J.S., Fish D.C. Neurological and physiological responses of the primate to anthrax toxin. J Infect Dis 1968, 118:85-96.
16. Walker J.S., Lincoln R.E., Klein F. Pathophysiological and biochemical changes in anthrax. Fed Proc 1967, 26:1539-1544.
17. van Sorge N.M., Ebrahimi C.M., McGillivray S.M., et al. Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis. PLoS One 2008, 3:e2964.
18. Tessier J., Green C., Padgett D., et al. Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis. Infect Immun 2007, 75:1895-1903.
19. Alkan A., Sarac K., Kutlu R., et al. Proton MR spectroscopy features of normal appearing white matter in neurofibromatosis type 1. Magn Reson Imaging 2003, 21:1049-1053.
20. Saindane A.M., Cha S., Law M., Xue X., Knopp E.A., Zagzag D. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002, 23:1378-1386.
21. Poptani H., Gupta R.K., Roy R., Pandey R., Jain V.K., Chhabra D.K. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995, 16:1593-1603.
22. Miller B.L. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 1991, 4:47-52.
23. Tartaglia M.C., Narayanan S., De Stefano N., et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 2002, 249:1382-1390.